As part of the Cancer Moonshot, representatives from government, academic, pharmaceutical and diagnostic companies are launching a new partnership in pursuit of creating an open database for liquid biopsies to potentially accelerate the development of safe and effective blood profiling diagnostic technologies for patient benefit.
The University of Michigan Comprehensive Cancer Center is one of 12 sites to joinPrecision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer.
Colorectal cancer is the second biggest cancer killer, trailing only lung cancer in the number of deaths each year. In time for Colorectal Cancer Awareness Month, University of Michigan Comprehensive Cancer Center experts outline genetic counseling, screening and treatment strategies for colorectal cancer.
A class of drugs that shows promise in breast and ovarian cancers with BRCA gene mutations could potentially benefit colorectal cancer patients with a different genetic mutation, a new study from the University of Michigan Comprehensive Cancer Center finds.
Colorectal cancer screening. Just the thought of it makes most people feel uneasy and embarrassed. But experts at the University of Michigan Comprehensive Cancer Center say choosing to ignore it could cost you your life.